Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Malempati S, Weigel BJ, Chi YY, Tian J, Anderson JR, Parham DM, Teot LA, Rodeberg DA, Yock TI, Shulkin BL, Spunt SL, Meyer WH, Hawkins DS. Malempati S, et al. Among authors: spunt sl. Cancer. 2019 Jan 15;125(2):290-297. doi: 10.1002/cncr.31770. Epub 2018 Oct 23. Cancer. 2019. PMID: 30351457 Free PMC article. Clinical Trial.
Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma.
Spunt SL, Lobe TE, Pappo AS, Parham DM, Wharam MD Jr, Arndt C, Anderson JR, Crist WM, Paidas C, Wiener E, Andrassy RJ, Schwartz CL. Spunt SL, et al. J Pediatr Surg. 2000 Feb;35(2):309-16. doi: 10.1016/s0022-3468(00)90030-7. J Pediatr Surg. 2000. PMID: 10693686
Routine brain imaging is unwarranted in asymptomatic patients with rhabdomyosarcoma arising outside of the head and neck region that is metastatic at diagnosis: a report from the Intergroup Rhabdomyosarcoma Study Group.
Spunt SL, Anderson JR, Teot LA, Breneman JC, Meyer WH, Pappo AS; Intergroup Rhabdomyosarcoma Study Group. Spunt SL, et al. Cancer. 2001 Jul 1;92(1):121-5. doi: 10.1002/1097-0142(20010701)92:1<121::aid-cncr1299>3.0.co;2-d. Cancer. 2001. PMID: 11443617
Soft tissue sarcomas of childhood.
Meyer WH, Spunt SL. Meyer WH, et al. Among authors: spunt sl. Cancer Treat Rev. 2004 May;30(3):269-80. doi: 10.1016/j.ctrv.2003.11.001. Cancer Treat Rev. 2004. PMID: 15059650 Review. No abstract available.
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Spunt SL, Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM, Link MP. Spunt SL, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6072-9. doi: 10.1158/1078-0432.CCR-04-0654. Clin Cancer Res. 2004. PMID: 15447992 Clinical Trial.
194 results